Epithelioid Haemangioendothelioma Observational Study
The Evaluation of Cytokines and Hormones as Biomarkers for Epithelioid Haemangioendothelioma and Generation of Patient-derived Preclinical Models to Assess the Activity of Anticancer Agents and Validate Novel Therapeutic Targets
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
50 participants
Feb 25, 2021
OBSERVATIONAL
Conditions
Summary
The EHE observational study was developed to obtain a high number of datas such as clinical presentation, natural history, and treatment outcomes, cto identificate cytokines and hormones as biomarkers and generate patient-derived preclinical models as a tool to assess the activity of anticancer agents and validate novel therapeutic targets
Eligibility
Inclusion Criteria4
- Histological diagnosis of EHE according to 2020 WHO classification, performed on biopsy or surgical specimen
- Signed informed consent
- Adequate patient compliance to treatment or follow up
- No age limit
Exclusion Criteria1
- Impossibility to ensure adequate compliance
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06680401